As of 27 October 2025, 24 countries in Africa have introduced malaria vaccines into their routine immunisation programmes with Gavi support.
As of 27 October 2025, 24 countries in Africa have introduced malaria vaccines into their routine immunisation programmes with Gavi support.
In December 2021, the Gavi Board made history by approving funding to support the roll-out of the world’s first malaria vaccine – nearly 35 years in development – in sub-Saharan Africa in 2022–2025. According to the World Health Organization (WHO), the vaccine is estimated to save 1 life for every 200 children vaccinated.
Consistent funding and investment are crucial to ensure this new, vital tool reaches equally all those who need it. As long as resources are available, Gavi pledges its continued commitment and support to the fight against one of Africa’s deadliest diseases.
Children aged under five years are at the greatest risk of dying from malaria and account for more than 75% of the global deaths from the disease. Unlike adults, young children have not had the opportunity to develop partial immunity through years of exposure, making them particularly at risk.
In 2023 alone, malaria caused 597,000 deaths globally, and 432,000 child deaths in Africa – highlighting the urgent need to protect our youngest and most vulnerable. The African region shoulders the heaviest malaria burden globally, accounting for about 94% of all cases and 95% of deaths, according to WHO data.
As of October 2025, over 39 million doses have been delivered to 25 endemic countries in Africa which have introduced malaria vaccines into routine immunisation with Gavi support:
Malaria vaccine safety and effectiveness: Both the RTS,S/AS01 and R21/Matrix-M vaccines are prequalified and recommended by WHO to prevent malaria in children and are safe and effective.
Data arms Africa’s fight against malaria
African nations need to tailor interventions based on the local setting as blanket approaches spread precious resources too thin. African countries use data-driven approaches to battle malaria, maximising impact with limited resources.
The difference a vaccine can make
A health worker in Malawi sees the impact of the new malaria vaccine first hand.
Malaria experts call for action on growing drug resistance in Africa
Patterns of artemisinin resistance in South-East Asia are being detected across Africa, threatening a “ticking time bomb” of malaria deaths.
Could malaria stage a comeback in the US, Europe and elsewhere because of climate change?
The mosquitoes that spread malaria are expanding their geographic distributions because of warming temperatures and altered rainfall patterns.
“I’ve had enough of witnessing despair”: relief and hope greet Benin’s malaria vaccine roll-out
On April 25, Benin will begin administering RTS,S malaria vaccines to children, in a move experts anticipate will turn the tide on a disease that claims more than 10,000 lives a year.
Vaccines will begin to roll out on 25 April in Sierra Leone – not a moment too soon for a country in which malaria accounts for half of all childhood hospital visits.
Ghana sees falling malaria burden, targets elimination
One of three countries that began rolling out the world’s first malaria vaccine in 2019, Ghana aims to eliminate the parasitic scourge. Francis Kokutse spoke to health leaders to establish exactly what that means.
Malawi health workers report drop in malaria cases following vaccine intro
This rainy season, referral hospitals in Malawi have found themselves able to dedicate resources to other priorities, following a drop in childhood malaria cases.
Five innovations that could help to eliminate malaria
Recently approved malaria vaccines have reinvigorated hopes of eliminating the disease, but other innovations are in development that could further bolster these efforts.
Two vaccines, one target: How the RTS,S and R21 malaria vaccines work
After decades of development and testing, the malaria vaccines now being rolled out across Africa are the first to ever successfully target a parasite, rather than a virus or bacterium. But how do these revolutionary vaccines work?
Cameroon’s malaria vaccination roll-out finds an enthusiastic reception
Though new vaccines often meet with parental wariness, health workers on the ground say mums and babies are turning out in force for the RTS,S jab.
Will we get a travel vaccine against malaria?
A vaccine that protects travellers against malaria would be useful, but scientists are testing their efficacy in other groups first.
